Key points are not available for this paper at this time.
A polymorphism consisting of the presence or absence of a 250-bp DNA fragment was detected within the angiotensin I-converting enzyme gene (ACE) using the endothelial ACE cDNA probe. This polymorphism was used as a marker genotype in a study involving 80 healthy subjects, whose serum ACE levels were concomitantly measured. Allele frequencies were 0.6 for the shorter allele and 0.4 for the longer allele. A marked difference in serum ACE levels was observed between subjects in each of the three ACE genotype classes. Serum immunoreactive ACE concentrations were, respectively, 299.3 +/- 49, 392.6 +/- 66.8, and 494.1 +/- 88.3 micrograms/liter, for homozygotes with the longer allele (n = 14), and heterozygotes (n = 37) and homozygotes (n = 29) with the shorter allele. The insertion/deletion polymorphism accounted for 47% of the total phenotypic variance of serum ACE, showing that the ACE gene locus is the major locus that determines serum ACE concentration. Concomitant determination of the ACE genotype will improve discrimination between normal and abnormal serum ACE values by allowing comparison with a more appropriate reference interval.
Building similarity graph...
Analyzing shared references across papers
Loading...
Brigitte Rigat
Groupe Hospitalier du Havre
C. Hübert
Institute of Structural and Molecular Biology
F Alhenc‐Gelas
Inserm
Journal of Clinical Investigation
Inserm
Collège de France
Institut National de Santé Publique
Building similarity graph...
Analyzing shared references across papers
Loading...
Rigat et al. (Mon,) studied this question.
synapsesocial.com/papers/6a0f253914089a5783bdc20c — DOI: https://doi.org/10.1172/jci114844
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: